Sridevi Khambhampaty

Sridevi Khambhampaty

Active Director Ceo DIN 08742296
DIN 08742296 First appointment May 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2020
Shareholding value •••• Premium profile

About Sridevi Khambhampaty

Data last updated:

Sridevi Khambhampaty is a Ceo at Shilpa Biologicals Private Limited (since 2024) and Director at Emplace Research Private Limited (since 2020). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹85.37 Cr; the largest is Shilpa Biologicals Private Limited at ₹85.24 Cr (FY 2025).

DIN 08742296
Primary Designation Ceo
Industry Pharma
First Appointment 15 May 2020
Oldest Company Age 6 yrs
Largest company Shilpa Biologicals Private Limited · ₹85.24 Cr (FY 2025)
Combined revenue ₹85.37 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shilpa Biologicals Private Limited U24230KA2020PTC131456
Ceo19 Sep 20242020₹85.24 Cr (FY 2025)Active
Emplace Research Private Limited U73100TG2020PTC140325
Director15 May 20202020₹12.4 Lakh (FY 2023)Active

Directorship timeline

Open interactive timeline →
Shilpa Biologicals Private Limited
Emplace Research Private Limited
Premium access

Shareholding and investment profile for Sridevi Khambhampaty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sridevi Khambhampaty

Sridevi Khambhampaty currently holds 2 directorships: Shilpa Biologicals Private Limited (Ceo, since 19 Sep 2024, revenue ₹85.24 Cr (FY 2025)); Emplace Research Private Limited (Director, since 15 May 2020, revenue ₹12.4 Lakh (FY 2023)).

Sridevi Khambhampaty was first appointed on 15 May 2020 as Director at Emplace Research Private Limited. The most recent appointment on record is 19 Sep 2024 at Shilpa Biologicals Private Limited.

The 2 current companies of Sridevi Khambhampaty that report revenue have a combined latest revenue of ₹85.37 Cr: Shilpa Biologicals Private Limited ₹85.24 Cr (FY 2025); Emplace Research Private Limited ₹12.4 Lakh (FY 2023).

The current boards of Sridevi Khambhampaty's companies include Anita Bandyopadhyay (Shilpa Biologicals Private Limited), Anushiya Bhandari (Shilpa Biologicals Private Limited), Madhav Vishnukant Bhutada (Shilpa Biologicals Private Limited), Ramakant Innani (Shilpa Biologicals Private Limited), Venkatesh Sharma (Shilpa Biologicals Private Limited), Vishnukanth Chaturbhuj Bhutada (Shilpa Biologicals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available